136 related articles for article (PubMed ID: 553397)
1. Humoral immunity in myasthenia gravis: immunoglobulin class, affinity, and antigenic site.
Tindall RS
Trans Am Neurol Assoc; 1979; 104():16-8. PubMed ID: 553397
[No Abstract] [Full Text] [Related]
2. Humoral pathogenesis of myasthenia gravis.
Drachman DB; de Silva S; Ramsay D; Pestronk A
Ann N Y Acad Sci; 1987; 505():90-105. PubMed ID: 2446560
[No Abstract] [Full Text] [Related]
3. Increased uptake of acetylcholine-receptor antibody at motor endplate in myasthenic exacerbation.
de Crousaz G; Fulpius BW
Lancet; 1978 Jan; 1(8054):47. PubMed ID: 74528
[No Abstract] [Full Text] [Related]
4. [Pseudo-internuclear ophthalmoplegia in myasthenia gravis].
Bogdan I; Crisanda V
Oftalmologia; 2011; 55(3):70-3. PubMed ID: 22428294
[TBL] [Abstract][Full Text] [Related]
5. The role of humoral immunity in myasthenia gravis.
Zurn AD; Fulpius BW
Prog Brain Res; 1979; 49():435-40. PubMed ID: 229518
[No Abstract] [Full Text] [Related]
6. Immunopathogenesis and treatment of myasthenia gravis.
Levinson AI; Zweiman B; Lisak RP
J Clin Immunol; 1987 May; 7(3):187-97. PubMed ID: 3036906
[No Abstract] [Full Text] [Related]
7. Idiotypes and anti-idiotypes of human autoantibodies to the acetylcholine receptor in myasthenia gravis.
Lefvert AK
Monogr Allergy; 1987; 22():57-70. PubMed ID: 3325836
[No Abstract] [Full Text] [Related]
8. Genetic and antibody-mediated channelopathies at the neuromuscular junction.
Vincent A; Mills K
Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():250-8. PubMed ID: 10689470
[No Abstract] [Full Text] [Related]
9. Progress in the understanding of myasthenia gravis pathogenesis.
Heilbronn E
Prog Clin Biol Res; 1980; 39():391-405. PubMed ID: 6995993
[No Abstract] [Full Text] [Related]
10. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
de Crousaz G
Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
[No Abstract] [Full Text] [Related]
11. Humoral immunity in myasthenia gravis: relationship to disease severity and steroid treatment.
Bradley RJ; Dwyer D; Morley BJ; Robinson G; Kemp GE; Oh SJ
Lancet; 1978 Jul; 2(8080):96. PubMed ID: 78314
[No Abstract] [Full Text] [Related]
12. Anti-acetylcholine receptor idiotypes in myasthenia gravis analysed by rabbit anti-sera.
Lang B; Roberts AJ; Vincent A; Newsom-Davis J
Clin Exp Immunol; 1985 Jun; 60(3):637-44. PubMed ID: 4017289
[TBL] [Abstract][Full Text] [Related]
13. Myasthenia gravis: pathogenesis and treatment.
Richman DP; Agius MA
Semin Neurol; 1994 Jun; 14(2):106-10. PubMed ID: 7984824
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis and pathophysiology of myasthenia gravis--electrophysiological, ultrastructural and immunological aspects of neuromuscular junctions (author's transl)].
Takamori M; Tsujihata M; Ide Y; Eguchi K; Mine M
No To Shinkei; 1980 Sep; 32(9):891-908. PubMed ID: 6254548
[No Abstract] [Full Text] [Related]
15. Myasthenia gravis: acetylcholine receptor antibodies and beyond.
Burde RM
J Clin Neuroophthalmol; 1981 Mar; 1(1):63-6. PubMed ID: 6213647
[No Abstract] [Full Text] [Related]
16. Autoimmune myasthenia gravis in childhood.
Andrews PI
Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
[TBL] [Abstract][Full Text] [Related]
17. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
Barkas T; Simpson JA
J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of myasthenia gravis.
Hughes BW; Moro De Casillas ML; Kaminski HJ
Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
[TBL] [Abstract][Full Text] [Related]
19. Seronegative myasthenia gravis.
Vincent A; McConville J; Farrugia ME; Newsom-Davis J
Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis: remission not induced by blocking anti-idiotype antibodies.
Heininger K; Hendricks M; Toyka KV; Kolb H
Muscle Nerve; 1983 Jun; 6(5):386-7. PubMed ID: 6888417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
